639 related articles for article (PubMed ID: 18729021)
21. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
Surewicz WK; Jones EM; Apetri AC
Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
[TBL] [Abstract][Full Text] [Related]
22. Identification of proteins with high affinity for refolded and native PrPC.
Petrakis S; Sklaviadis T
Proteomics; 2006 Dec; 6(24):6476-84. PubMed ID: 17111435
[TBL] [Abstract][Full Text] [Related]
23. Cell-free formation of protease-resistant prion protein.
Kocisko DA; Come JH; Priola SA; Chesebro B; Raymond GJ; Lansbury PT; Caughey B
Nature; 1994 Aug; 370(6489):471-4. PubMed ID: 7913989
[TBL] [Abstract][Full Text] [Related]
24. Slow virus disease: deciphering conflicting data on the transmissible spongiform encephalopathies (TSE) also called prion diseases.
Bastian FO; Fermin CD
Microsc Res Tech; 2005 Nov; 68(3-4):239-46. PubMed ID: 16276518
[TBL] [Abstract][Full Text] [Related]
25. [Prion protein and copper: a mysterious relationship].
Rachidi W; Riondel J; McMahon HM; Favier A
Pathol Biol (Paris); 2005 May; 53(4):244-50. PubMed ID: 15850959
[TBL] [Abstract][Full Text] [Related]
26. Structural insights into the interaction between prion protein and nucleic acid.
Lima LM; Cordeiro Y; Tinoco LW; Marques AF; Oliveira CL; Sampath S; Kodali R; Choi G; Foguel D; Torriani I; Caughey B; Silva JL
Biochemistry; 2006 Aug; 45(30):9180-7. PubMed ID: 16866364
[TBL] [Abstract][Full Text] [Related]
27. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
28. Prion channel proteins and their role in vacuolation and neurodegenerative diseases.
Kourie JI
Eur Biophys J; 2002 Sep; 31(5):409-16. PubMed ID: 12202918
[TBL] [Abstract][Full Text] [Related]
29. Pathogenesis of prion diseases: current status and future outlook.
Aguzzi A; Heikenwalder M
Nat Rev Microbiol; 2006 Oct; 4(10):765-75. PubMed ID: 16980938
[TBL] [Abstract][Full Text] [Related]
30. Towards cellular receptors for prions.
Lee KS; Linden R; Prado MA; Brentani RR; Martins VR
Rev Med Virol; 2003; 13(6):399-408. PubMed ID: 14625887
[TBL] [Abstract][Full Text] [Related]
31. Prions and peripheral nerves: a deadly rendezvous.
Heikenwalder M; Julius C; Aguzzi A
J Neurosci Res; 2007 Sep; 85(12):2714-25. PubMed ID: 17393538
[TBL] [Abstract][Full Text] [Related]
32. A mathematical analysis of the dynamics of prion proliferation.
Greer ML; Pujo-Menjouet L; Webb GF
J Theor Biol; 2006 Oct; 242(3):598-606. PubMed ID: 16753184
[TBL] [Abstract][Full Text] [Related]
33. Prions: protein aggregation and infectious diseases.
Aguzzi A; Calella AM
Physiol Rev; 2009 Oct; 89(4):1105-52. PubMed ID: 19789378
[TBL] [Abstract][Full Text] [Related]
34. Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: implications for the mechanism of prion formation.
Cappai R; Stewart L; Jobling MF; Thyer JM; White AR; Beyreuther K; Collins SJ; Masters CL; Barrow CJ
Biochemistry; 1999 Mar; 38(11):3280-4. PubMed ID: 10079070
[TBL] [Abstract][Full Text] [Related]
35. Prion diseases: from molecular biology to intervention strategies.
Nunziante M; Gilch S; Schätzl HM
Chembiochem; 2003 Dec; 4(12):1268-84. PubMed ID: 14661267
[TBL] [Abstract][Full Text] [Related]
36. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
[TBL] [Abstract][Full Text] [Related]
37. Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds?
Caughey B; Caughey WS; Kocisko DA; Lee KS; Silveira JR; Morrey JD
Acc Chem Res; 2006 Sep; 39(9):646-53. PubMed ID: 16981681
[TBL] [Abstract][Full Text] [Related]
38. Semiautomated cell-free conversion of prion protein: applications for high-throughput screening of potential antiprion drugs.
Breydo L; Bocharova OV; Baskakov IV
Anal Biochem; 2005 Apr; 339(1):165-73. PubMed ID: 15766724
[TBL] [Abstract][Full Text] [Related]
39. Prions and prion diseases: fundamentals and mechanistic details.
Ryou C
J Microbiol Biotechnol; 2007 Jul; 17(7):1059-70. PubMed ID: 18051314
[TBL] [Abstract][Full Text] [Related]
40. Theoretical analysis of the implication of PrP in neuronal death during transmissible subacute spongiform encephalopathies: hypothesis of a PrP oligomeric channel.
Chapron Y; Peyrin JM; Crouzy S; Jaegly A; Dormont D
J Theor Biol; 2000 May; 204(1):103-11. PubMed ID: 10772851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]